| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
2 companies
Levine James E. is a Chief Financial Officer at Cardiff Oncology, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 11 buys and 0 sells.
Estimated insider holdings value: $212K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2024 | CRDF Cardiff Oncology, Inc. | Chief Financial Officer | Buy | 7,716 | $4.76 | $36,725.50 | +4.1% | -15.6% | -44.3% | |
| Sep 16, 2022 | CRDF Cardiff Oncology, Inc. | Chief Financial Officer | Buy | 30,000 | $1.56 | $46,710.00 | +100.0% | -11.4% | +9.5% | |
| Sep 10, 2021 | CRDF Cardiff Oncology, Inc. | Chief Financial Officer | Buy | 30,000 | $6.47 | $194,000.00 | +50.0% | -8.3% | -54.0% | |
| Nov 10, 2020 | Chief Financial Officer | Buy | 50,000 | $2.01 | $100,720.00 | New | - | - | ||
| Sep 24, 2019 | Chief Financial Officer | Buy | 30,000 | $1.91 | $57,240.00 | +17.1% | - | - |